USC Norris cancer research ranks among top clinical advances
Research from the USC Norris Comprehensive Cancer Center that identifies specific genes that need to be turned off in order for cancer cells to survive was named one of the top 20 …
Research from the USC Norris Comprehensive Cancer Center that identifies specific genes that need to be turned off in order for cancer cells to survive was named one of the top 20 …
Call it the magnet effect: A run of recruiting success at USC attracts new scholars who, in turn, become powerful draws for top colleagues, students and supporters. Magnet faculty newly recruited from …
Certain mutated cells keep trying to replicate their DNA — with disastrous results — even after medications rob them of the raw materials to do so, according to new research from USC.
Andrew P. McMahon, newly appointed department chair of stem cell biology and regenerative medicine at the Keck School of Medicine of USC and director of the Eli and Edythe Broad Center for …
A study appearing in Cell Stem Cell and led by researchers at the University of Southern California, outlines the specifics of how autoimmune disorders can be controlled by infusions of mesenchymal stem …
The V Foundation for Cancer Research recently honored Christina Curtis, assistant professor of preventive medicine at the Keck School of Medicine of USC, with one of only 17 2012 V Scholar grants. …
Three groups of USC researchers representing medicine, chemistry and chemical engineering are recipients of highly competitive grants from the National Cancer Institute (NCI) at the National Institutes of Health (NIH). Challenging investigators …
California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM) has approved $5.7 million for a USC researcher to help move promising stem cell-based therapies from the laboratory research phase to …
It was standing room only at the first Stem Cell Symposium hosted by the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC.
Stem cell researchers at USC have received a $1.75 million grant to engineer transplantable liver cells from discarded human placenta, a potential cure for certain congenital metabolic disorders. If successful, the proposed …